Short Bowel Syndrome Drugs Market Size, Share, Trends & Growth Forecast 2032
Short Bowel Syndrome (SBS) is a rare, chronic malabsorption disorder resulting from extensive surgical resection of the small intestine (often due to Crohn’s disease, mesenteric ischemia, volvulus, trauma, or congenital defects). It leads to severe diarrhea, malnutrition, dehydration, electrolyte imbalances, and dependence on long-term parenteral nutrition (PN). The global SBS drugs...
0 Commenti 0 condivisioni 35 Views